Home/Filings/8-K/0001217234-26-000007
8-K//Current report

CareDx, Inc. 8-K

Accession 0001217234-26-000007

$CDNACIK 0001217234operating

Filed

Jan 11, 7:00 PM ET

Accepted

Jan 12, 7:08 AM ET

Size

192.4 KB

Accession

0001217234-26-000007

Research Summary

AI-generated summary of this filing

Updated

CareDx, Inc. Announces Preliminary Q4 and Full-Year 2025 Results

What Happened

  • On January 12, 2026, CareDx, Inc. (CDNA) filed a Form 8-K (Item 2.02) to announce that it issued a press release with its preliminary unaudited financial results for the quarter and year ended December 31, 2025. The press release is attached to the 8-K as Exhibit 99.1 and is incorporated by reference.

Key Details

  • Filing date: January 12, 2026 (Form 8-K, Item 2.02).
  • Period covered: quarter and fiscal year ended December 31, 2025.
  • Disclosure format: preliminary, unaudited financial results announced via press release (Exhibit 99.1).
  • Legal note (Item 9.01 language): the furnished information is not “filed” for Section 18 liability purposes and is not automatically incorporated by reference into other filings.

Why It Matters

  • This 8-K gives investors an early, company-provided view of CareDx’s recent quarterly and full-year performance (earnings/revenue/other financials) for 2025. Because the numbers are preliminary and unaudited, they may be revised when CareDx files its formal periodic reports (e.g., Form 10-K or 10-Q). Investors should review the attached press release (Exhibit 99.1) for the specific figures and monitor subsequent SEC filings for the final audited results.